Document FOR IMMEDIATE RELEASE Labcorp Contacts Investors Christin O'Donnell - 336-436-5076 Investor Labcorp.com Media Kimbrel Arculeo - 336-436-8263 Media Labcorp.com Labcorp Declares Quarterly Dividend BURLINGTON, N.C.
Thursday, October 10, 2024 1 min read
Key Takeaway: Labcorp has announced a quarterly cash dividend of $0.72 per share, payable on December 13, 2024, to stockholders on record as of November 26, 2024. The company, based in Burlington, N.C., has established itself as a leader in laboratory services and diagnostics. With over 67,000 employees, Labcorp supports healthcare globally, notably contributing to a significant percentage of new drug approvals by the FDA in 2023.
Market Sentiment Analysis
POSITIVE FACTORS
Labcorp declared a quarterly cash dividend of $0.72 per share.
The payout demonstrates the company's commitment to returning value to shareholders.
Labcorp is a global leader in laboratory services, impacting healthcare positively.
Support for 84% of new FDA-approved drugs in 2023 highlights its significance.
Full Press Release Details
Investors Christin O'Donnell - 336-436-5076
Investor Labcorp.com
Media Kimbrel Arculeo - 336-436-8263
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., October 10, 2024 - Labcorp (NYSE LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13, 2024, to stockholders of record as of the close of business on November 26, 2024.
Labcorp (NYSE LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.
Frequently Asked Questions
What is Labcorp's recent dividend announcement?
Labcorp has declared a cash dividend of $0.72 per common share.
When will Labcorp's dividend be paid?
The dividend will be payable on December 13, 2024.
Who is eligible for Labcorp's dividend?
Stockholders of record as of November 26, 2024, are eligible.
What services does Labcorp provide?
Labcorp offers comprehensive lab services for health and drug development.
How many tests did Labcorp perform last year?
Labcorp conducted over 600 million tests for patients in 2023.